Fundraising Fox

Civitas Therapeutics

Chelsea, US · Founded 2009 · 6 known investors

civitastherapeutics.com ↗
Biotech

Founders & leadership

RH
ROB HOPFNERNamed on SEC filing
BJ
BLAIR JACKSONNamed on SEC filing
BS
BRYAN STUARTNamed on SEC filing
TS
TIMOTHY S. NELSONNamed on SEC filing
RS
RAJEEV SHAHNamed on SEC filing
MI
MARK IWICKINamed on SEC filing
RB
RICHARD BATYCKYNamed on SEC filing
TS
TIM SHANNONNamed on SEC filing
GB
GLENN BATCHELDERNamed on SEC filing
DH
DAVID HIRSCHNamed on SEC filing
MF
MARTIN FREEDNamed on SEC filing
RR
ROBERT ROCHENamed on SEC filing

Investors · 6

Canaan PartnersStamford · $500K – $20M
Sofinnova VenturesMenlo Park · $100K – $15M
Bay City CapitalreportedSan Rafael · $5M – $10M
Longitude CapitalreportedMenlo Park · $10M – $30M
OrbiMedreportedNew York · $1M – $75M
RA CapitalreportedBoston

Reported raises · per SEC filings

Form D private placements

$55.3M disclosed across 1 round · 2014

▶$55.3MraisedAug 2014 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROB HOPFNERDirector
  • BLAIR JACKSONDirector
  • BRYAN STUARTExecutive Officer
  • TIMOTHY S. NELSONDirector
  • RAJEEV SHAHDirector
  • MARK IWICKIExecutive Officer, Director
  • RICHARD BATYCKYExecutive Officer
  • TIM SHANNONDirector
  • GLENN BATCHELDERDirector
  • DAVID HIRSCHDirector
  • MARTIN FREEDExecutive Officer
  • ROBERT ROCHEDirector
  • AIDAN KINGDirector
  • ANDREA FRANZExecutive Officer
  • MARY TAYLORExecutive Officer
Offering amount
$55.3M
Amount sold
$55.3M
First sale
Aug 2014
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Parkinson's biotech Civitas Therapeutics officially withdraws IPO; acquired by Acorda for $525 million | Nasdaqnasdaq.com · Dec 2014Massachusetts' Civitas Therapeutics Locks In $55 Million - BioSpacebiospace.com · Aug 2014Civitas Therapeutics receives $38m in financing to further develop inhaled Parkinson's drug - Clinical Trials Arenaclinicaltrialsarena.com · Sep 2013Civitas Therapeutics Raises $38 Million - BioSpacebiospace.com · Sep 2013Civitas Therapeutics Secures $20 Million Series A Financing - BioSpacebiospace.com · Jan 2011Civitas Therapeutics raises $38m with Irish backing -globalventuring.com

Frequently asked questions

Who are Civitas Therapeutics's investors?
Civitas Therapeutics's investors include Canaan Partners, Sofinnova Ventures, Bay City Capital, Longitude Capital, OrbiMed, RA Capital.
How much funding has Civitas Therapeutics raised?
Civitas Therapeutics has disclosed $55.3M raised across 1 round.
Where is Civitas Therapeutics headquartered?
Civitas Therapeutics is headquartered in Chelsea, US.